JASPREET KAUR: Open Payments
NPI 1710498530 · MANHASSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 32 payments from 11 companies in 2025. Trend: 2023 $407 · 2024 $533 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| Botanix SB Inc | 13 | $169 |
| Incyte Corporation | 4 | $109 |
| PFIZER INC. | 4 | $69 |
| Amgen Inc. | 3 | $59 |
| LEO Pharma Inc. | 2 | $51 |
| GENZYME CORPORATION | 1 | $28 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| UCB, Inc. | 1 | $19 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Chiesi USA, Inc. | 1 | $14 |
Products named: SOFDRA, OPZELURA, CIBINQO, OTEZLA, DUPIXENT, ADBRY, ANZUPGO, Winlevi.
Industry payments across NY — which companies pay providers there.
